Ipilimumab vs Lenalidomide Hydrochloride Monohydrate

## Ipilimumab vs Lenalidomide Hydrochloride Monohydrate: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Lenalidomide Hydrochloride Monohydrate**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Lenalidomide Hydrochloride Monohydrate — N/A.

## Chemical Properties

**Type**: Ipilimumab — Antibody; Lenalidomide Hydrochloride Monohydrate — Small molecule.